Supriya Lifescience Limited has informed the Exchange that Board of Directors at its meeting held on May 27, 2025, recommended Final Dividend of Re. 1 per equity share.
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 0.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of Supriya Lifescience Limited, at its meeting held on May 27, 2025, has recommended a Final Dividend of Re. 1 per equity share for its shareholders. This is a routine corporate action declared after the financial year's results. The final dividend will be subject to shareholder approval at the upcoming Annual General Meeting (AGM). The record date and book closure dates for the dividend will typically be announced separately by the company.
The Re. 1 per share dividend is modest and represents a small cash return to shareholders. Investors should consider the dividend yield relative to the share price to assess its actual impact. The declaration reflects consistent profitability but is unlikely to materially move the stock price.